✦ For YouGeopoliticsTechFinanceHealthEnergySportsCulture◆ SN Last Week★ Saved

STAT+: Talawar bets bispecific approach can shake up eczema market

By STAT News · Summarized & edited by · 2026-06-29
STAT+: Talawar bets bispecific approach can shake up eczema market

Get the Health newsletter

Daily health & science — research, biotech, public health, the studies worth knowing. Free.

Moderna still bullish on mRNA, Ipsen's acquisition of Kartos, and more biotech news from The Readout

Share this story

𝕏 Twitter in LinkedIn 💬 WhatsApp
Ask SkimNews
More health → Read original →

Related stories

STAT+: Radiopharmaceutical shows promise in post-Pluvicto setting
STAT+: Radiopharmaceutical shows promise in post-Pluvicto setting Health
 STAT+: Roche ends Huntington’s gene-silencing programs
STAT+: Roche ends Huntington’s gene-silencing programs Health
 STAT+: Abivax ulcerative colitis drug shows strong efficacy, but cases of cancer raise concerns
STAT+: Abivax ulcerative colitis drug shows strong efficacy, but cases of cancer raise concerns Health
 STAT+: A patent win for Pfizer and BridgeBio
STAT+: A patent win for Pfizer and BridgeBio Health
 STAT+: A standing ovation for RevMed, and caution for Akeso
STAT+: A standing ovation for RevMed, and caution for Akeso Health

Get the Health newsletter

Curated health stories, every morning. Free.

No spam. Unsubscribe anytime.